Dirk Evers is VP of data operations at Molecular Health in Heidelberg, Germany. Previously, he was senior VP of informatics at the New York Genome Center and also served as the director of computational biology at Illumina. He holds a PhD in bioinformatics from Bielefeld University.
NanoString Technologies has appointed David Ghesquiere as senior VP of corporate and business development. Ghesquiere joins NanoString from Dendreon, where he served as senior VP of corporate and business development. He has also served executive roles with OSI Pharmaceuticals (acquired by Astellas) and Aventis Pharmaceuticals (acquired by Sanofi).